Candriam SCA’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-145,191
| Closed | -$5.84M | – | 690 |
|
|
2025
Q1 | $5.84M | Sell |
145,191
-25,369
| -15% | -$1.02M | 0.04% | 301 |
|
|
2024
Q4 | $8.02M | Sell |
170,560
-8,640
| -5% | -$406K | 0.05% | 296 |
|
|
2024
Q3 | $9.46M | Hold |
179,200
| – | – | 0.05% | 277 |
|
|
2024
Q2 | $9.71M | Sell |
179,200
-313,829
| -64% | -$17M | 0.06% | 255 |
|
|
2024
Q1 | $34.6M | Buy |
493,029
+225,789
| +84% | +$15.8M | 0.22% | 108 |
|
|
2023
Q4 | $22.3M | Sell |
267,240
-236,000
| -47% | -$19.7M | 0.15% | 148 |
|
|
2023
Q3 | $14.8M | Sell |
503,240
-35,000
| -7% | -$1.03M | 0.11% | 181 |
|
|
2023
Q2 | $17.6M | Hold |
538,240
| – | – | 0.13% | 177 |
|
|
2023
Q1 | $17.4M | Buy |
538,240
+35,000
| +7% | +$1.13M | 0.12% | 187 |
|
|
2022
Q4 | $23.1M | Hold |
503,240
| – | – | 0.16% | 153 |
|
|
2022
Q3 | $24.4M | Sell |
503,240
-17,236
| -3% | -$835K | 0.17% | 133 |
|
|
2022
Q2 | $20.4M | Sell |
520,476
-119,752
| -19% | -$4.7M | 0.17% | 139 |
|
|
2022
Q1 | $23.6M | Buy |
640,228
+126,884
| +25% | +$4.67M | 0.16% | 144 |
|
|
2021
Q4 | $23.4M | Hold |
513,344
| – | – | 0.15% | 157 |
|
|
2021
Q3 | $18.3M | Hold |
513,344
| – | – | 0.12% | 188 |
|
|
2021
Q2 | $10.2M | Buy |
513,344
+137,491
| +37% | +$2.72M | 0.07% | 281 |
|
|
2021
Q1 | $7.5M | Hold |
375,853
| – | – | 0.06% | 305 |
|
|
2020
Q4 | $7.81M | Buy |
375,853
+235,628
| +168% | +$4.9M | 0.06% | 313 |
|
|
2020
Q3 | $3.04M | Buy |
+140,225
| New | +$3.04M | 0.03% | 435 |
|